Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers

Unlike many conventional cancers with preferential patterns of oncogenic genetic alterations, TRK fusions resulting from NTRK1/2/3 genetic alterations drive oncogenic transformations in more than 20 different ...

Source: Journal of Hematology and Oncology - June 7, 2018 Category: Hematology Authors: Yu Chen and Ping Chi Tags: Research highlight Source Type: research